Zhenqi Liu and former UVA graduate student Nathan Weeldreyer, found about 40% of the weight people lose using brand-name drugs like Wegovy or Zepbound comes from something called fat-free mass, which is everything in your body that is not fat
This finding of a putative Tregitope in the N-terminus of TPT has important implications for the immunogenicity of peptide impurities in generic drug products
Atorvastatin in a dose of 10 mg/day, 20 mg/day, and 40 mg/day by 20%, 22.6%, and 26.8%, respectively, and rosuvastatin at the same doses by 19.8%, 23.7%, and 26.1%, respectively
This is a common issue across the GLP-1 protein supplement category, where many products provide subtherapeutic doses
The FDA has approved several blood thinners since 2010, including Pradaxa, Xarelto, Eliquis and Savaysa
Clinical trials studying semaglutide for weight management evaluated longer-term use